Ketamine inhibits K+ evoked [3H] noradrenaline release from SH-SY5Y cells by reducing calcium influx.
Sikand
K S
KS
University Department of Anaesthesia, Leicester Royal Infirmary, UK.
Smith
G
G
Lambert
D G
DG
D000778:Anesthetics, Dissociative / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism*; D015220:Calcium Channels / Q000187:drug effects / Q000378:metabolism; D002460:Cell Line; D006801:Humans; D017136:Ion Transport / Q000187:drug effects; D007649:Ketamine / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism*; D011188:Potassium / Q000494:pharmacology*; D016194:Receptors, N-Methyl-D-Aspartate / Q000037:antagonists & inhibitors
D000778:Anesthetics, Dissociative; D015220:Calcium Channels; D016194:Receptors, N-Methyl-D-Aspartate; D007649:Ketamine; D011188:Potassium; D002118:Calcium; D009638:Norepinephrine